Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABCN VIVO Cannabis	C$1.32 +5.6%	C$1.32	C$0.80 ▼ C$4.06	C$256.62M	N/A	1.51 million shs	310,601 shs
ATTBF Abattis Bioceuticals		$0.00	$0.00 ▼ $0.00	N/A	N/A	11,650 shs	N/A
GBLX GB Sciences	$0.01	$0.01	$0.01 ▼ $0.02	N/A	N/A	127,598 shs	20,951 shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABCN VIVO Cannabis	0.00%	0.00%	0.00%	0.00%	0.00%
ATTBF Abattis Bioceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
GBLX GB Sciences	-1.92%	-4.48%	+16.36%	+16.36%	-61.45%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GBLX GB Sciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A
GBLX GB Sciences	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A	N/A
GBLX GB Sciences	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABCN VIVO Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	-$0.16	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GBLX GB Sciences	N/A	-$0.30	N/A	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABCN VIVO Cannabis	N/A	N/A	N/A	N/A	N/A
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
GBLX GB Sciences	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	32.45%
GBLX GB Sciences	13.56%

Insider Ownership

Company	Insider Ownership
ABCN VIVO Cannabis	N/A
ATTBF Abattis Bioceuticals	N/A
GBLX GB Sciences	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ABCN VIVO Cannabis	N/A	194.41 million	N/A	Not Optionable
ATTBF Abattis Bioceuticals	N/A	N/A	N/A	Not Optionable
GBLX GB Sciences	3	N/A	N/A	Not Optionable

GBLX, ATTBF, ABCN, ABZA, and AHZ Headlines

Source	Headline
	A Natural History of Domesticated Mammals cambridge.org - March 24 at 3:07 AM
	GB News posts £42m loss but grows online audience bbc.com - March 12 at 7:38 PM
	Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland® miamiherald.com - December 14 at 10:26 AM
	Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R) finance.yahoo.com - December 14 at 10:26 AM
	Family and Consumer Sciences uwyo.edu - November 13 at 3:20 PM
	Team GB News: Medals and Schedule at Winter Olympics dailymail.co.uk - November 2 at 8:15 AM
	Dan Wootton's replacement on GB News revealed as he's suspended over Laurence Fox rant mirror.co.uk - October 8 at 9:57 AM
	GB News suspends Laurence Fox as he refuses to apologise for 'totally unacceptable' comments about Ava Evans news.sky.com - October 6 at 2:04 AM
	GB News boss explains why Dan Wootton is still on air amid allegations against presenter mirror.co.uk - October 6 at 2:04 AM
	GB News suspends third presenter for supporting Dan Wootton in Laurence Fox row mirror.co.uk - October 3 at 10:18 AM
	GB News - Updates on the British television news channel dailymail.co.uk - October 2 at 12:36 AM
	Inaugural Session - Science Summit at the UN General Assembly \| SSUNGA 78 alphagalileo.org - September 7 at 10:20 PM
	HEALTH SCIENCES COMPLEX udel.edu - September 6 at 8:11 AM
	Gb Sciences’ First-in-Class Parkinson’s Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge miamiherald.com - July 11 at 8:10 AM
	Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge finance.yahoo.com - July 11 at 8:10 AM
	Paddington (GB) bloodhorse.com - July 9 at 7:40 AM
	GB-Eire Time zone • Current Time in GB-Eire prokerala.com - June 22 at 11:59 AM
	INSIGHT-Lab crunch: British science has nowhere to go reuters.com - June 20 at 11:08 AM
	GBLX - GB Sciences, Inc. finance.yahoo.com - May 27 at 12:19 PM
	GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China finance.yahoo.com - March 20 at 9:41 AM
	Successful 2022 Milestones Support Value of Gb Sciences’ AI-Enabled Drug Discovery Platform newsobserver.com - March 7 at 10:46 AM
	Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform finance.yahoo.com - March 7 at 10:46 AM
	Who are GB News’ presenters? Everything you need to know pressgazette.co.uk - February 22 at 10:22 AM
	GB Sciences Stock (OTC:GBLX), Quotes and News Summary benzinga.com - February 18 at 1:49 AM

New MarketBeat Followers Over Time

Company Descriptions

VIVO Cannabis

CVE:ABCN

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals

OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

GB Sciences

OTCMKTS:GBLX

GB Sciences, Inc., a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial